Watch on YouTube: https://youtube.com/watch?v=ev4_zfwqi5k

In this video, Manish Goel explains Customer Concentration Risk — the most overlooked danger in Indian small-cap investing. Learn what it is, why it destroys portfolios, how to measure it using annual reports, and how Titan Biotech’s extraordinary 100-country export diversification makes it a structural quality benchmark.

Key topics covered: What is customer concentration risk, why Indian small-caps are especially vulnerable, how to find concentration data in annual reports, Titan Biotech’s 100-country export fortress, and the 5-point framework for evaluating any stock.

Subscribe to our YouTube channel and join our Telegram community at @longtermequityy for daily value investing insights.

🎓 Complete Value Investing Course: Watch Full Playlist

SEBI Disclaimer: 9 out of 10 individual traders in the equity Futures & Options segment incurred net losses according to a SEBI study. F&O trading is essentially gambling. Focus on quality stock picking and long-term value investing instead.

Disclaimer: The author (Manish Goel) is a SEBI Registered Research Analyst (Registration No. INH100004775) and Manish Goel Portfolio Management Service (Manish Goel) is a SEBI Registered Research Analyst (Registration No. INH100004775). This post is for educational purposes only. Not investment advice.